Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…

CertaraJune 18, 2026

Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…

CertaraJune 16, 2026

Webinar

Building IND-Ready and Investor-Ready Development Programs

CertaraJune 15, 2026

Blog

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…

CertaraJune 15, 2026

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

CertaraJune 11, 2026

Blog

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…

CertaraJune 11, 2026

Live Events

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

June 30, 2026 - 12:00 PM – 2:00 PM

CertaraJune 10, 2026

On-Demand Webinar

Model Smarter, Not Harder: Introducing Model Designer

Watch Model Designer on demand: Certara's browser based tool for faster NLME model discovery, configuration,…

CertaraJune 10, 2026

Poster

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.

CertaraJune 9, 2026

Press Coverage

The Case for Simulating Pregnancy

Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how…

CertaraJune 9, 2026

Modeling and Simulation

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Building IND-Ready and Investor-Ready Development Programs

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

2026 Simcyp Workshops

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

Model Smarter, Not Harder: Introducing Model Designer

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

The Case for Simulating Pregnancy

Newsletter sign up

Quick links

Solutions

Contact